All Stories

  1. Respiratorische Erkrankungen
  2. Acute Hemodynamic Effects of Sotatercept
  3. Dual Impacts of Lung Transplantation on the Recovery and Comorbidity of Interstitial Lung Diseases: A Longitudinal Assessment of the Benefits and Burden
  4. Increase in Alveolar Septal Width Is a Histological Predictor of Chronic Lung Allograft Dysfunction and Survival in Lung Transplant Recipients—A Longitudinal Study
  5. Method for generating right ventricular pressure-volume loops in routine practice
  6. Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis
  7. Echocardiographic Measure of Right Ventricular–Pulmonary Arterial Coupling Predicts Survival in Lung Cancer
  8. Right-sided heart failure in acute respiratory distress syndrome
  9. Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta‐Registry
  10. Automated CT Image Processing for the Diagnosis, Prediction, and Differentiation of Phenotypes in Chronic Lung Allograft Dysfunction After Lung Transplantation
  11. Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry
  12. Exercise Limitation in Pulmonary Hypertension – Physiological Insights into the 6-Minute Walk Test
  13. The Diagnostic Accuracy of an Electrocardiogram in Pulmonary Hypertension and the Role of “R V1, V2 + S I, aVL − S V1”
  14. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension
  15. Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study
  16. Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension
  17. A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding
  18. Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension
  19. Changes in Doppler‐Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure
  20. Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension
  21. Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters
  22. The C0-C1f Region of Cardiac Myosin Binding Protein-C Induces Pro-Inflammatory Responses in Fibroblasts via TLR4 Signaling
  23. Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension
  24. Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
  25. Pulmonary complications of tyrosine kinase inhibitors in myeloproliferative disorders
  26. Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
  27. Risk assessment in severe pulmonary hypertension due to interstitial lung disease
  28. Sex Differences in Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension
  29. Impact of timing on right heart catheterization measurements in pulmonary hypertension
  30. Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker?
  31. Reliability of echo systolic pulmonary arterial pressure to detect new definition of pulmonary hypertension
  32. Risk assessment in severe pulmonary hypertension due to interstitial lung disease
  33. In-depth risk stratification in pulmonary arterial hypertension
  34. Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study
  35. Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?
  36. P4764Development of a qualitative and quantitative detection method for the N-terminal fragment of cardiac myosin-binding protein C